|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-12-8
|
|
pubmed:abstractText |
After curative resection for pancreatic cancer, only 10% of patients survive disease for 5 years. These dismal results suggest the presence of occult tumor at the time of initial operation. This phase I/II study was conducted to compare traditional exploratory laparotomy with radioimmunoguided surgery (RIGS) in the assessment of disseminated pancreatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0039-6060
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
122
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
867-71; discussion 871-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9369885-Adenocarcinoma,
pubmed-meshheading:9369885-Antibodies, Monoclonal,
pubmed-meshheading:9369885-Antigens, Neoplasm,
pubmed-meshheading:9369885-Humans,
pubmed-meshheading:9369885-Immunohistochemistry,
pubmed-meshheading:9369885-Iodine Radioisotopes,
pubmed-meshheading:9369885-Keratins,
pubmed-meshheading:9369885-Laparoscopy,
pubmed-meshheading:9369885-Liver Neoplasms,
pubmed-meshheading:9369885-Lymphatic Metastasis,
pubmed-meshheading:9369885-Neoplasm Metastasis,
pubmed-meshheading:9369885-Pancreatic Neoplasms,
pubmed-meshheading:9369885-Radioimmunodetection,
pubmed-meshheading:9369885-Survival Rate,
pubmed-meshheading:9369885-Time Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Assessment of disseminated pancreatic cancer: a comparison of traditional exploratory laparotomy and radioimmunoguided surgery.
|
|
pubmed:affiliation |
Department of Surgery, Ohio State University College of Medicine, Arthur G. James Cancer Hospital, Columbus, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
